VCAM1 and neoplasm: TAMs improve the interaction between α4-integrin and vascular cell adhesion molecule-1 (VCAM-1) on the tumor cells, so they can activate the PI3K/Akt pathway and protect the tumor cells against pro-apoptotic activities such as TRAIL [65].